PO86 | Emicizumab in patients with moderate hemophilia A and severe bleeding phenotype: Single-center real-world experience. PAGEPress Publications.
Chicago Style (17th ed.) CitationPO86 | Emicizumab in Patients with Moderate Hemophilia A and Severe Bleeding Phenotype: Single-center Real-world Experience. PAGEPress Publications.
MLA (9th ed.) CitationPO86 | Emicizumab in Patients with Moderate Hemophilia A and Severe Bleeding Phenotype: Single-center Real-world Experience. PAGEPress Publications.
Warning: These citations may not always be 100% accurate.